2021 Biotech Stock Picking Charity Contest Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2021 Biotech Stock Picking Charity Contest

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: technetium	10/16/2021 1:16:59 PM
	of 307

CTSO Brilliant analysis for a biotech stock (NOT): “Given that Cytosorbents didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. When a company doesn't make profits, we'd generally expect to see good revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.” finance.yahoo.com Somebody who clearly does not understand the concept that a huge amount of money has to be spent, typically for a decade or two, before you have a chance of getting a return on your investment. Most biotechs are good ideas spun out of research labs that have to go through the grind of the clinical approval process on the public dime of the stock market and perhaps some private investment. Big pharma used to do this sort of thing entirely in house, where the public did not know how many good ideas died on the vine or perhaps were nipped in the bud too soon. Consider the biotech field as hot house flowers, where some thrive under the right conditions, and others fall by the wayside, either because the idea was never going to work in the first place, or because it didn’t have the right people to nurture it to a successful outcome. Not everything works. Even the “rapid” turn around on getting Covid vaccines approved rested on decades of research into vaccines in general, and on SARS viruses in particular. Standing on the shoulders of giants… en.wikipedia.org The quote is most often attributed to Sir Isaac Newton in a letter to his rival, Robert Hooke, though by that time Newton and Hooke were on good terms. Isaac Newton remarked in a letter to his rival Robert Hooke dated 5 February 1676 [O.S.] [10] (15 February 1676 [N.S.]) that: What Des-Cartes [ sic] did was a good step. You have added much several ways, & especially in taking the colours of thin plates into philosophical consideration. If I have seen further it is by standing on the sholders [sic] of Giants.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next